首页> 外文期刊>Clinical oncology >Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.
【24h】

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.

机译:转移性骨痛的姑息治疗:单部分放疗与多部分放疗–随机试验的系统评价。

获取原文
获取原文并翻译 | 示例
       

摘要

Recent randomised studies have reported that single fraction radiotherapy is as effective as multifraction radiotherapy in relieving pain caused by bone metastasis. However, there are concerns about the higher re-treatment rates and the efficacy of preventing future complications, such as pathological fracture and spinal cord compression, by single fraction radiotherapy. A systematic review of randomised studies, examining the effectiveness of single fraction radiotherapy versus multiple fraction radiotherapy for metastatic bone pain relief and prevention of bone complications, was conducted to help answer this controversy. Randomised studies comparing single fraction radiotherapy with multifraction radiotherapy on metastatic bone pain were identified. The analyses were performed using intention-to-treat principle. The results were pooled using meta-analysis to estimate the effect of treatment on pain response, re-treatment rate, pathological fracture rate and spinal cord compression rate. Twelve trials involving 3621 sites were included in the meta-analysis. The overall pain-response rates for single fraction radiotherapy and multifraction radiotherapy were 60% (1080/1814) and 59% (1060/1807), respectively, giving an odds ratio (OR) of 1.03 (95% confidence interval [CI] 0.90-1.19), indicating no difference between the two radiotherapy schedules. There was also no difference in complete pain response rates for single fraction radiotherapy (34% [508/1476]) and multifraction radiotherapy (32% [475/1473]), with an OR of 1.10 (950% CI 0.94-1.30). Patients treated by single fraction radiotherapy had a higher re-treatment rate, with 21.5% (267/1240) requiring re-treatment compared with 7.4% (91/1236) of patients in the multifraction radiotherapy arm (OR 3.44 [95% CI 2.67-4.43]). The pathological fracture rate was also higher in single fraction radiotherapy arm patients. Three per cent (37/1240) of patients treated by single fraction radiotherapy developed pathological fracture compared with 1.6% (20/1236) for those treated by multifraction radiotherapy (OR 1.82 [95% CI 1.06-3.11]). The spinal cord compression rates were similar for both arms (OR 1.41 [95% CI 0.72-2.75]). Single fraction radiotherapy was as effective as multifraction radiotherapy in relieving metastatic bone pain. However, the re-treatment rate and pathological fracture rate were higher after single fraction radiotherapy. Studies with quality of life and health economic end points are warranted to find out the optimal treatment option.
机译:最近的随机研究报道,单级放疗与多级放疗在缓解骨转移引起的疼痛方面一样有效。然而,人们担心更高的再治疗率以及通过单次放射疗法预防未来并发症(例如病理性骨折和脊髓压迫)的功效。进行了一项随机研究的系统综述,以检查单次放疗与多次放疗对转移性骨痛缓解和预防骨并发症的有效性,以帮助回答这一争议。确定了将单次放疗与多次放疗对转移性骨痛进行比较的随机研究。使用意向性治疗原理进行分析。使用荟萃分析汇总结果,以评估治疗对疼痛反应,再治疗率,病理性骨折率和脊髓压迫率的影响。荟萃分析包括十二项涉及3621个位点的试验。单级放疗和多级放疗的总体疼痛缓解率分别为60%(1080/1814)和59%(1060/1807),比值比(OR)为1.03(95%置信区间[CI] 0.90) -1.19),表示两个放疗时间表之间没有差异。单级放疗(34%[508/1476])和多级放疗(32%[475/1473])的完全疼痛缓解率也没有差异,OR为1.10(950%CI 0.94-1.30)。单次放疗治疗的患者有更高的再治疗率,需要再治疗的比例为21.5%(267/1240),而多次放疗组的患者为7.4%(91/1236)(OR 3.44 [95%CI 2.67 -4.43])。单部分放射治疗组患者的病理性骨折率也更高。单次放疗治疗的患者中有3%(37/1240)发生了病理性骨折,而多次放疗的患者则为1.6%(20/1236)(OR 1.82 [95%CI 1.06-3.11])。两组的脊髓压迫率相似(OR 1.41 [95%CI 0.72-2.75])。单级放疗与多级放疗在缓解转移性骨痛方面一样有效。然而,单次放疗后的再治疗率和病理性骨折率较高。必须对生活质量和健康经济终点进行研究,以找到最佳治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号